0001628280-23-016560.txt : 20230508
0001628280-23-016560.hdr.sgml : 20230508
20230508182907
ACCESSION NUMBER: 0001628280-23-016560
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230505
FILED AS OF DATE: 20230508
DATE AS OF CHANGE: 20230508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GIVEN DOUGLAS B
CENTRAL INDEX KEY: 0001156207
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38042
FILM NUMBER: 23899366
MAIL ADDRESS:
STREET 1: C/O NEORX CORP
STREET 2: 410 WEST HARRISON ST
CITY: SEATTLE
STATE: WA
ZIP: 98119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARROWHEAD PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000879407
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460408024
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 177 E COLORADO BLVD
STREET 2: SUITE 700
CITY: PASADENA
STATE: CA
ZIP: 91105
BUSINESS PHONE: 626-696-4702
MAIL ADDRESS:
STREET 1: 177 E COLORADO BLVD
STREET 2: SUITE 700
CITY: PASADENA
STATE: CA
ZIP: 91105
FORMER COMPANY:
FORMER CONFORMED NAME: ARROWHEAD RESEARCH CORP
DATE OF NAME CHANGE: 20040112
FORMER COMPANY:
FORMER CONFORMED NAME: INTERACTIVE GROUP INC
DATE OF NAME CHANGE: 20020509
FORMER COMPANY:
FORMER CONFORMED NAME: INTERACTIVE INC
DATE OF NAME CHANGE: 19940224
4
1
wf-form4_168358492995664.xml
FORM 4
X0407
4
2023-05-05
0
0000879407
ARROWHEAD PHARMACEUTICALS, INC.
ARWR
0001156207
GIVEN DOUGLAS B
177 E. COLORADO BLVD
SUITE 700
PASADENA
CA
91105
1
0
0
0
0
Common Stock
2023-05-05
4
S
0
6500
40.90
D
117635
D
Common Stock
13000
I
By Trust
Common Stock
12500
I
By Trust
The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $40.59 to $41.22, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
Includes previously reported shares of common stock underlying Restricted Stock Units granted to the reporting person which are subject to certain vesting conditions.
Represents securities owned directly by Anne Given Trust ("AG Trust"). Douglas Given, as co-trustee of AG Trust, may be deemed to beneficially own the securities owned directly by AG Trust.
Represents securities owned directly by Katherine Given Ligtenberg Trust ("KGL Trust"). Douglas Given, as co-trustee of KGL Trust, may be deemed to beneficially own the securities owned directly by KGL Trust.
/s/Douglass Given
2023-05-05